
Schlumberger (SLB) has garnered significant investor attention, though its shares declined 1.2% over the past month, underperforming the S&P 500 and its industry. While the company recently missed revenue and EPS estimates for the last reported quarter, analysts project current fiscal year earnings to decline 9.4% to $3.09, with a 4.6% increase expected for the next fiscal year. Despite a Zacks Value Style Score of 'B' indicating it trades at a discount, Zacks assigns SLB a 'Hold' (Rank #3) rating, suggesting potential near-term performance in line with the broader market.
Schlumberger (SLB) is exhibiting a mixed fundamental picture, characterized by recent underperformance and near-term headwinds, contrasted with potential future growth and an attractive valuation. The stock's -1.2% return over the past month lags both the S&P 500 composite's +5.1% gain and its own industry's +1.9% rise. This weakness follows a recent quarter where the company missed consensus estimates, reporting revenues of $8.49 billion (-1.27% vs. consensus) and EPS of $0.72 (-2.7% vs. consensus). Looking ahead, analyst estimates project continued pressure, with current-quarter EPS expected to decline 11.8% and full-year EPS to fall 9.4% year-over-year. Correspondingly, full-year revenue is forecast to contract by 0.8%. A potential inflection point appears in the next fiscal year, with consensus estimates pointing to a 6.2% revenue increase and a 4.6% earnings expansion. However, these future estimates have also been revised downward by 1.2% over the last 30 days, signaling tempered analyst confidence. Despite the challenging outlook, SLB's valuation appears favorable, as indicated by its Zacks Value Style Score of 'B', suggesting it trades at a discount to its peers. The resulting Zacks Rank of #3 (Hold) appropriately reflects these conflicting signals, suggesting the stock may perform in line with the broader market in the near term.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Overall Sentiment
mixed
Sentiment Score
-0.05
Ticker Sentiment